| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8285602 | Parkinsonism & Related Disorders | 2018 | 4 Pages |
Abstract
This article notes the advantage to clinical research and treatment by considering these two syndromes as the same so that medications approved for PDD and for PD psychosis can be extended to DLB patients and that resources for PD research and support can be also used for DLB.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Ageing
Authors
Joseph H. MD,